电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SARS-CoV-2 Nucleocapsid 抗体

This anti-SARS-CoV-2 Nucleocapsid antibody is a 小鼠 单克隆 antibody detecting SARS-CoV-2 Nucleocapsid in . Suitable for SARS Coronavirus-2 (SARS-CoV-2).
产品编号 ABIN7794936
发货至: 中国

Quick Overview for SARS-CoV-2 Nucleocapsid 抗体 (ABIN7794936)

抗原

See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) 抗体
SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

适用

  • 145
  • 37
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

宿主

  • 85
  • 29
  • 28
  • 8
  • 4
  • 3
  • 1
  • 1
小鼠

克隆类型

  • 125
  • 18
  • 15
单克隆

标记

  • 105
  • 24
  • 16
  • 8
  • 1
  • 1
  • 1
  • 1
  • 1
This SARS-CoV-2 Nucleocapsid antibody is un-conjugated

应用范围

请咨询

克隆位点

NP1-B9
  • 原理

    Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-B9) Purified No Carrier Protein

    特异性

    Anti-SARS-CoV-2 Nucleocapsid, clone NP1-B9, specifically targets an epitope on the SARS-CoV-2 nucleocapsid protein. Futhermore, it is reported to bind to the oligomerization domain of the N protein. Antigen Distribution The nucleocapsid protein is expressed in the internal nucleocapsid of SARS-CoV-2. Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus belonging to the Coronaviridae family1. The SARS-CoV-2 genome encodes four essential proteins the spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins2. SARS-CoV-2 shares 79.6 % identity with the original SARS-CoV2. The N protein is 46 kDa and consists of two highly conserved structural domains, the N-terminal domain (NTD) and C-terminal domain (CTD), connected by a linker region. The NTD and CTD are involved in a couple of primary functions, including RNA binding and self-oligomerization3,4. This results in binding to and packaging of the viral RNA genome into a helical ribonucleoprotein5. The N protein is involved in other critical steps of the viral life cycle, including transcription, replication, and modulating infected cell signaling pathways6,7. The N protein is a suitable candidate for vaccine development and diagnostic assays8 for several reasons. It is abundantly expressed during infection and is highly conserved, sharing 90 % amino acid homology with the SARS-CoV N protein9. Furthermore, antibodies9,10 and memory T cells11,12 targeting the N protein are identified in the sera of convalescent COVID-19 patients, demonstrating it as immunogenic. The N protein also suppresses antiviral RNAi, evading the innate immune system13, suggesting its potential value as a targeted therapeutic.

    纯化方法

    Recombinant antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

    纯度

    >=90 % monomer by analytical SEC and SDS-Page

    亚型

    IgG1
  • 限制

    仅限研究用
  • 浓度

    1 μg/mL

    缓冲液

    This recombinant monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.

    储存液

    Without preservative

    储存条件

    4 °C,-80 °C

    储存方法

    This antibody may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at <= -70°C.Avoid Repeated Freeze Thaw Cycles.
  • 抗原

    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

    别名

    SARS-CoV-2 Nucleocapsid (N)

    物质类

    Viral Protein

    背景

    COV2-NP1-B9, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein,
You are here:
Chat with us!